Gemcitabine for the treatment of metastatic breast cancer

  • Technology appraisal guidance
  • TA116
  • Published: 
Download guidance (PDF)

1 Guidance

1.1 Gemcitabine in combination with paclitaxel, within its licensed indication, is recommended as an option for the treatment of metastatic breast cancer only when docetaxel monotherapy or docetaxel plus capecitabine are also considered appropriate.